BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 337856)

  • 1. Relationship of the serum concentration of pancuronium to its neuromuscular activity in man.
    Agoston S; Crul JF; Kersten UW; Scaf AH
    Anesthesiology; 1977 Dec; 47(6):509-12. PubMed ID: 337856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of pancuronium and neuromuscular blockade after injection into the isolated arm, bolus injection, and continuous infusion.
    Agoston S; Feldman SA; Miller RD
    Anesthesiology; 1979 Aug; 51(2):119-22. PubMed ID: 453611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response and plasma concentration-response relationships of pancuronium in man.
    Shanks CA; Somogyi AA; Triggs EJ
    Anesthesiology; 1979 Aug; 51(2):111-8. PubMed ID: 453610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium carbonate and neuromuscular blocking agents.
    Hill GE; Wong KC; Hodges MR
    Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular effects of enflurane, alone and combined with d-Tubocurarine, pancuronium, and succinylcholine, in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1975 Feb; 42(2):173-8. PubMed ID: 1115366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of neuromuscular block in the diaphragm and hand after administration of tubocurarine, pancuronium and alcuronium.
    Derrington MC; Hindocha N
    Br J Anaesth; 1990 Mar; 64(3):294-9. PubMed ID: 2328177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of atracurium by pancuronium and d-tubocurarine.
    Gerber HR; Romppainen J; Schwinn W
    Can Anaesth Soc J; 1986 Sep; 33(5):563-70. PubMed ID: 3533236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine potentiates nondepolarizing neuromuscular relaxants in a primate.
    Tsai SK; Lee C
    Anesth Analg; 1989 Jan; 68(1):5-8. PubMed ID: 2562910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in pancuronium requirement, plasma concentration, and urinary excretion induced by cardiopulmonary bypass with hypothermia.
    d'Hollander AA; Duvaldestin P; Henzel D; Nevelsteen M; Bomblet JP
    Anesthesiology; 1983 Jun; 58(6):505-9. PubMed ID: 6859580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1977 Aug; 12(1):23-9. PubMed ID: 332502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans.
    Donati F; Antzaka C; Bevan DR
    Anesthesiology; 1986 Jul; 65(1):1-5. PubMed ID: 3729027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of pancuronium during predetermined intensities of neuromuscular blockade.
    Shanks CA; Somogyi AA; Triggs EJ
    Br J Anaesth; 1978 Mar; 50(3):235-9. PubMed ID: 637996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of rapid endotracheal intubations with divided doses of nondepolarizing neuromuscular blocking drugs.
    Mehta MP; Choi WW; Gergis SD; Sokoll MD; Adolphson AJ
    Anesthesiology; 1985 Apr; 62(4):392-5. PubMed ID: 3157332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of pancuronium on masseter and adductor pollicis muscles in humans.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):57-61. PubMed ID: 2751140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine.
    Donati F; McCarroll SM; Antzaka C; McCready D; Bevan DR
    Anesthesiology; 1987 Apr; 66(4):471-6. PubMed ID: 3565812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1976 Sep; 10(5):367-72. PubMed ID: 789085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of neuromuscular transmission by electromyography during anaesthesia. A comparison with mechanomyography in cat and man.
    Engbaek J
    Dan Med Bull; 1996 Sep; 43(4):301-16. PubMed ID: 8884132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade.
    Donati F; Lahoud J; McCready D; Bevan DR
    Can J Anaesth; 1987 Nov; 34(6):589-93. PubMed ID: 3677283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.